AT355237B - Verfahren zur herstellung neuer halogenderivate in der reihe des 16 alpha- methylpregnans - Google Patents

Verfahren zur herstellung neuer halogenderivate in der reihe des 16 alpha- methylpregnans

Info

Publication number
AT355237B
AT355237B AT136577A AT136577A AT355237B AT 355237 B AT355237 B AT 355237B AT 136577 A AT136577 A AT 136577A AT 136577 A AT136577 A AT 136577A AT 355237 B AT355237 B AT 355237B
Authority
AT
Austria
Prior art keywords
pregnans
range
producing new
alpha methyl
halogen derivatives
Prior art date
Application number
AT136577A
Other languages
German (de)
English (en)
Other versions
ATA136577A (de
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ATA136577A publication Critical patent/ATA136577A/de
Application granted granted Critical
Publication of AT355237B publication Critical patent/AT355237B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT136577A 1976-03-02 1977-03-01 Verfahren zur herstellung neuer halogenderivate in der reihe des 16 alpha- methylpregnans AT355237B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7605854A FR2342738A1 (fr) 1976-03-02 1976-03-02 Nouveaux derives halogenes de la serie du 16a-methyl pregnane

Publications (2)

Publication Number Publication Date
ATA136577A ATA136577A (de) 1979-07-15
AT355237B true AT355237B (de) 1980-02-25

Family

ID=9169832

Family Applications (1)

Application Number Title Priority Date Filing Date
AT136577A AT355237B (de) 1976-03-02 1977-03-01 Verfahren zur herstellung neuer halogenderivate in der reihe des 16 alpha- methylpregnans

Country Status (16)

Country Link
JP (1) JPS52106855A (fi)
AT (1) AT355237B (fi)
AU (1) AU509948B2 (fi)
BE (1) BE851944A (fi)
CA (1) CA1082170A (fi)
CH (1) CH619969A5 (fi)
DE (1) DE2709078C2 (fi)
DK (1) DK156401C (fi)
FR (1) FR2342738A1 (fi)
GB (1) GB1530975A (fi)
IE (1) IE44866B1 (fi)
LU (1) LU76867A1 (fi)
NL (1) NL7702166A (fi)
PT (1) PT66261B (fi)
SE (1) SE7702250L (fi)
ZA (1) ZA771078B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2462443A1 (fr) * 1979-07-26 1981-02-13 Roussel Uclaf Nouveau derive halogene de la serie du 16a-methyl pregnane, son procede de preparation et son application comme medicament
FR2533928A1 (fr) * 1982-10-05 1984-04-06 Roussel Uclaf Nouveaux derives dichlores de la serie du 16a-methyl pregnane, leur procede de preparation et leur application comme medicaments
DE4433374A1 (de) * 1994-09-20 1996-03-21 Hoechst Ag 17-Desoxi-corticosteroid-21-/O/-Carbonsäure- ester, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB928301A (en) * 1958-06-20 1963-06-12 Scherico Ltd 9, 11-dihalogeno steroids
US3049554A (en) * 1959-06-01 1962-08-14 Schering Corp 9, 11-dihalogeno-3, 20-diketopregnanes and processes for their manufacture

Also Published As

Publication number Publication date
ATA136577A (de) 1979-07-15
IE44866L (en) 1977-09-02
AU509948B2 (en) 1980-06-05
DK88277A (da) 1977-09-03
AU2280877A (en) 1978-09-07
PT66261B (fr) 1979-01-17
DK156401B (da) 1989-08-14
BE851944A (fr) 1977-09-01
PT66261A (fr) 1977-04-01
SE7702250L (sv) 1977-09-03
DE2709078A1 (de) 1977-09-08
CA1082170A (fr) 1980-07-22
IE44866B1 (en) 1982-04-21
DE2709078C2 (de) 1986-09-11
DK156401C (da) 1990-01-08
JPS6150960B2 (fi) 1986-11-06
JPS52106855A (en) 1977-09-07
FR2342738A1 (fr) 1977-09-30
GB1530975A (en) 1978-11-01
ZA771078B (en) 1978-04-26
LU76867A1 (fi) 1977-09-26
NL7702166A (nl) 1977-09-06
FR2342738B1 (fi) 1979-10-12
CH619969A5 (en) 1980-10-31

Similar Documents

Publication Publication Date Title
AT362364B (de) Verfahren zur herstellung neuer phenylimi- dazolidinonderivate
DD132869A5 (de) Verfahren zur herstellung neuer aminothiazolylazetamido-derivate
AT368755B (de) Verfahren zur herstellung neuer alkyl-ketohexopyranosidderivate
ATA60577A (de) Verfahren zur herstellung neuer polypeptidderivate
DD128133A5 (de) Verfahren zur herstellung neuer piperazinderivate
ATA151981A (de) Verfahren zur herstellung neuer benzopyranderivate
AT352918B (de) Verfahren zur herstellung neuer histidin- derivate
AT367403B (de) Verfahren zur herstellung neuer chinolin-2onderivate
AT358601B (de) Verfahren zur herstellung neuer nitrosoharn- stoff-derivate
DD134351A5 (de) Verfahren zur herstellung neuer pyridobenzodiazepinonen
AT355237B (de) Verfahren zur herstellung neuer halogenderivate in der reihe des 16 alpha- methylpregnans
AT375074B (de) Verfahren zur herstellung neuer halogenderivate des isopropylpyrimidins
ATA90478A (de) Verfahren zur herstellung neuer everninomicin- derivate
DD131558A5 (de) Verfahren zur herstellung neuer indolizinderivate
ATA736576A (de) Verfahren zur herstellung neuer indolderivate
AT359059B (de) Verfahren zur herstellung neuer 1-methyl-2- (phenyl-oxymethyl)-5-nitroimidazolderivate
AT356294B (de) Verfahren zur herstellung neuer ergolinderivate
DD133331A5 (de) Verfahren zur herstellung neuer basischer substituierter theophyllinderivate
DD128270A5 (de) Verfahren zur herstellung neuer azofarbstoffe
AT380014B (de) Verfahren zur herstellung neuer oxazolidin-2-on- derivate
DD130047A5 (de) Verfahren zur herstellung neuer aminoglykosidaminozyklitolderivate
DD134765A5 (de) Verfahren zur herstellung neuer indolylglyoxylsaeurederivate
AT372386B (de) Verfahren zur herstellung neuer ergopeptidalkaloidderivate
ATA947076A (de) Verfahren zur herstellung neuer ergolinderivate
ATA635377A (de) Verfahren zur herstellung neuer ergopeptidalkaloidderivate

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee